RxDoctor Payments Data

Vinod Voleti, MD

Retina Specialist · Morristown, NJNPI 1245452804

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (53.8%), food and beverage and education — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Carl Zeiss Meditec, Inc. at 53.8% of the total. Reporting peaked in 2024 at $2,702 and has fallen 84.6% since, to $417 in 2025.

$4,424in general payments, 2019–2025

Across 60 payments — averaging $73.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Carl Zeiss Meditec, Inc.$2K
  • Regeneron Healthcare Solutions, Inc.$1K
  • Astellas Pharma US Inc$198
  • AbbVie$175
  • Alcon$123
  • Johnson & Johnson Surgical Vision, Inc.$122
  • plus $425 from 9 others

What the payments were for

  • Consulting fees$2,38054%
  • Food & beverage$2,02146%
  • Education$231%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,424 in reported general payments places this provider in the 55th percentile of 35 retina specialist providers in New Jersey.

See all retina specialist providers in New Jersey

Medicare billing

Part B allowed, 2024
$6,045,081
Medicare patients
1,072
Services billed
35,572

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ProlensaBromfenac Sodium43$24,733
Bromfenac Sodium43$10,281
Prednisolone Acetate125$6,511
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol25$2,952
TobradexTobramycin/Dexamethasone11$2,883
Ketorolac Tromethamine59$2,595
ValacyclovirValacyclovir Hcl11$767
Brimonidine Tartrate20$567
Ofloxacin37$497
Latanoprost37$492
Dorzolamide Hcl23$377
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat20$359
Timolol Maleate15$114

Paid to pharmacies, not to this prescriber.

Other retina specialist in Morristown

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →